Fortrea Holdings Inc. (FTRE) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $8.39 - $21.39

3.3 Year FTRE Performance Metrics:

Total Return (with DRIP): -37.7% (-13.34% CAGR)

Total Return (no DRIP): -37.7% (-13.34% CAGR)

Share Price: -37.7% (-13.34% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $6,234

Total Return $ (with DRIP): -$3,766

FTRE Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

FTRE Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for FTRE

Based on past 3.3-year performance, here are FTRE growth metrics:

Share price CAGR of -13.34%
Dividend CAGR of +0%

Using FTRE CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	FTRE (DRIP)	FTRE - No DRIP
Current Price	$19.95	$19.95
Start Shares	501.25	501.25
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	501.25	501.25
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$4.77	$19.95
Total Dividends	$0	$0
Final Value	$2,389	$10,000

Estimated Future Value + Dividends - FTRE

NOTE: Above numbers are our estimate based on FTRE's Dividend and Price CAGR over past 3.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Fortrea Holdings Inc. (FTRE) had its IPO on , and is traded on NASDAQ stock exchange.

Fortrea Holdings Inc. is a global contract research organization that provides clinical development solutions to pharmaceutical, biotechnology, and medical device companies. Fortrea Holdings Inc. supports clients across the full clinical trial lifecycle, including Phase I through Phase IV studies, clinical pharmacology, data management, biostatistics, regulatory support, and post-approval evidence services. The company offers flexible delivery models such as full-service, functional service provider, and hybrid arrangements to fit different development needs. Its services are used by biopharma and medtech customers seeking to manage complex trials, improve operational efficiency, and generate the clinical evidence needed to advance products through development and approval. Fortrea Holdings Inc. is headquartered in Durham, North Carolina, and operates as a specialized services provider in the life sciences market.

FTRE website: https://www.fortrea.com